Image
Mini-Curriculum

Trends in Infectious Diseases: Updates on Treatment & Prevention Strategies for HIV and HCV

HIV Can Be Prevented— Are You Doing Your Part?

Clinical Practice Guidelines & Recommendations

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations on the International Antiviral Society-USA Panel

Saag MS, et al. JAMA. 2018;320(4):379-396.

Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement.

USPSTF. JAMA. 2019;321(22):2203-2213.

Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2017 Update. Clinical Practice Guideline

Centers for Disease Control and Prevention, 2017.

Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2017 Update. Clinical Provider’s Supplement

Centers for Disease Control and Prevention, 2017.

Quick Reference Guide: Recommended Laboratory HIV Testing Algorithm for Serum or Plasma Specimens.

Centers for Disease Control and Prevention, 2018.

STD and HIV Screening Recommendations.

Centers for Disease Control and Prevention, 2015.

Clinical Resources

American Academy of HIV Medicine | Supporting the HIV Care Provider and the Profession.

 

Basic Statistics.

Centers for Disease Control and Prevention, April 2019.

Center of Excellence for Transgender Health.

University of California, San Francisco, School of Medicine, 2018.

Database of Antiretroviral Drug Interactions.

HIV InSite. University of California, San Francisco.

A Guide to Taking a Sexual History.

Centers for Disease Control and Prevention.

HIV Among Youth.

Centers for Disease Control and Prevention, April 2019.

HIV in the United States by Region

Centers for Disease Control and Prevention, 2018.

HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017.

Centers for Disease Control and Prevention, 2018.

National College Health Assessment II.

American College Health Association, 2015.

PrEP Training Curriculum Modules

Developed by the South African HIV Clinicians Society, this training curriculum is for implementers rolling out PrEP. Modules are available on the PrEP Watch website.

Sexually Transmitted Diseases.

Centers for Disease Control and Prevention, 2019.

Southeast AETC (AIDS Education & Training Center Program)

Patient Resources

Centers for Disease Control and Prevention (CDC): HIV Basics.

The CDC is a division within the US Department of Health and Human Services (DHHS), the principal agency for protecting the health of all Americans. This comprehensive site provides extensive links to topics across the HIV-care continuum, including preexposure prophylaxis (PrEP).

HIV Risk Reduction Tool.

Centers for Disease Control and Prevention.

Suggested Readings

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Baeten JM, et al. N Engl J Med. 2012;367(5):399-410.

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.

Choopanya K, et al. Lancet. 2013;381(9883):2083-2090.

Implementation of a rapid entry program decreases time to viral suppression among vulnerable persons living with HIV in the southern United States.

Colasanti J, et al. Open Forum Infect Dis. 2018;5(6):ofy104.

Being PrEPared – preexposure prophylaxis and HIV disparities.

Goldstein RH, et al. N Engl J Med. 2018;379(14):1293-1295

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Grant RM, et al. N Engl J Med. 2010;363(27):2587-2599.

HIV Preexposure prophylaxis, by race and ethnicity – United States, 2014-2016.

Huang YA, et al. MMWR Morb Mortal Wkly Rep. 2018;67(41):1147-1150.

Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.

Molina JM, et al. Lancet HIV. 2017;4(9):e402-e410.

Challenges in translating PrEP interest into uptake in an observational study of young black MSM.

Rolle CP, et al. J Acquir Immun Defic Syndr. 2017;76(3):250-258.

Willingness to use pre-exposure prophylaxis among black and white men who have sex with men in Atlanta, Georgia.

Rolle CP, et al. Int J STD AIDS. 2017;28(9):849-857.

Activity
Trends in Infectious Diseases: Updates on Treatment & Prevention Strategies for HIV and HCV

HIV Can Be Prevented— Are You Doing Your Part?

Relevant Resources

PrEP for Your Patients’ Needs

The PCPs Role in Preventing HIV

BRIDGE HCV

Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV

Value-Based HIV Formularies

Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care

Targeting NASH

Advances in the Diagnosis and Treatment of Nonalcoholic Steatohepatitis

Hepatitis C is Curable

Got it? Treat it!

Real-World Issues in HIV Prevention & Treatment

The Critical Role of the Community Pharmacist

BLOCK HIV/HCV

Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.

Evolving Models of HIV Care

Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box

The Nexus of NASH and Type 2 Diabetes Mellitus

The Emerging Role of the Diabetologist

Updates in HCV Screening and Treatment

Key Issues Impacting OB/GYN Practice

The Big Picture of IBD

An Interactive Experience Highlighting Recent Clinical Advances

Clinical Issues in Chronic Liver Disease

Hot Topics in HBV, HCV, and NASH

The Changing Landscape of IBD

Emerging Concepts in Patient Management

The Big (& Small) Picture of Nonalcoholic Steatohepatitis

Building Your Understanding to Combat a Growing Problem

Evolving Models of HIV Care

Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice

Assessing Your Patients for HCV and HIV

Why It Matters in OB/GYN Practice Today

HIV as a Chronic Disease

A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities

The Pursuit of Hepatitis C Elimination

How the Pharmacist Can Make a Difference

Trends in Infectious Diseases: Updates on Treatment & Prevention Strategies for HIV and HCV

Understanding the Growing Syndemic — Opioids, HCV, and HIV